• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

COVID-19 Treatment and Vaccine Tracker Identifies New Treatments & Vaccines in Development

by Jasmine Pennic 03/30/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
COVID-19 Treatment and Vaccine Tracker Identifies New Treatments & Vaccines in Development

What You Should Know:

– The Milken Institute launched an effort to track and disseminate accurate information about COVID-19 treatments and vaccines in development.

– Since launch, more than two dozen new candidates have been identified, with some progressing toward clinical trials.


The Milken Institute COVID-19 Treatment and Vaccine Tracker has identified 16 new treatments in the pipeline along with nine new vaccine candidates since launching one week ago. Two potential vaccines have advanced to clinical trials. They are being developed by Moderna, Inc. and CanSino Biologics. In addition, the World Health Organization announced the global SOLIDARITY trial to develop treatments for the disease.

In total, the Milken Institute is now tracking 71 treatments and 47 vaccines in development. Treatments are grouped into candidate categories, including antibodies, antivirals, cell-based therapies, among others.

The tracker was updated to include more detail, including FDA-approved indications, clinical trials ongoing for other diseases, timing, as well as for vaccines, related uses, such as whether the same platform was used to create other vaccines and for which pathogens. In coming days, the tracker will include expanded information about clinical trials and the results for each candidate.

The COVID-19 Treatment and Vaccine Tracker is produced and maintained by FasterCures, a center of the Milken Institute, with an Advisory Council comprised of three former FDA chiefs, a Nobel Laureate biologist, and key industry leaders.

“We are continuing to see a full-court press from the biomedical research and development community to find a solution to the COVID-19 pandemic,” said Esther Krofah, executive director of FasterCures. “I am more hopeful than ever that there will be a surge of treatment and vaccine candidates making their way into clinical trials, and into the hands of patients.”

The Milken Institute COVID-19 vaccine development and treatment tracker is compiled from publicly available sources. The information in the tracker is updated regularly. 

The Milken Institute welcomes input on new vaccines and treatments in development. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |